Public calls

Every call the briefs have made in public, with the odds each edition printed and how it turned out, misses included.

From the editions you can open: each brief's latest, and back issues of the briefs you subscribe to. Odds and status are shown as printed.

Open · 3

  • Biotech & Pharma · call 12 · by 11.27

    FDA approves BridgeBio’s BBP-418 for limb-girdle muscular dystrophy 2I/R9

    Odds now60%

    As printed: “Open” · Biotech & Pharma · No. 052 ·

  • Biotech & Pharma · call 10 · by 11.30

    CMS publishes negotiated maximum fair prices for the 15 drugs selected for 2028

    Odds now90%

    As printed: “Open” · Biotech & Pharma · No. 052 ·

  • Biotech & Pharma · call 09 · by 12.31

    A biopharma acquisition of $5B or more is announced

    Odds now80%

    As printed: “Open” · Biotech & Pharma · No. 052 ·

Resolved · 0

No resolved calls in the editions you can open.